Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-25 @ 9:20 PM
Study NCT ID:
NCT01085656
Status:
TERMINATED
Last Update Posted:
2017-08-08
First Post:
2010-03-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
Sponsor:
University of Florida
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-11
First Submit QC Date:
None
Study First Post Date:
2010-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-07
Last Update Post Date:
2017-08-08
Last Update Post Date Type:
ACTUAL